Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty
NCT06234631Phase 2Recruiting
- Start
- Mar 2024
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in postoperative pain (4 arms). Primary endpoint: Total postoperative opioid consumption at 28 days. Started Mar 2024; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06234631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06234631.